Y. Brault

发表

Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the CRYSTEL study

T. Luger, C. Griffiths, C. Griffiths, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

A 24‐week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis

E. Berardesca, J. Ortonne, C. Paul, 2013, The British journal of dermatology.

Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis

C. Paul, Y. Brault, J. Stalder, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

Incidence of anemia in sirolimus‐treated renal transplant recipients: the importance of preserving renal function *

G. Russ, J. Chapman, P. Friend, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

The Influence of the Definition of Patient Global Assessment in Assessment of Disease Activity According to the Disease Activity Score (DAS28) in Rheumatoid Arthritis

M. Dougados, I. Logeart, P. Hilliquin, 2011, The Journal of Rheumatology.

Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group.

J. Sahel, G. Soubrane, Y. Brault, 1998, The British journal of ophthalmology.

Sirolimus‐Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years

T. Paavonen, M. Castagneto, J. Campistol, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients

J. Rovira, F. Diekmann, I. Revuelta, 2008, Transplant international : official journal of the European Society for Organ Transplantation.

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.

G. Russ, L. Rostaing, P. Friend, 2006, Journal of the American Society of Nephrology : JASN.

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

F. Schena, R. Oberbauer, J. Campistol, 2004, Journal of the American Society of Nephrology : JASN.

Regression of Left Ventricular Hypertrophy in Patients with Essential Hypertension Results of 6 Month Treatment with Indapamide

T. Ruddy, D. Guez, Y. Brault, 1995 .

Real-world Experience With Sunitinib Treatment in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to Risk Score.

C. Porta, S. Oudard, Y. Brault, 2019, Clinical genitourinary cancer.

Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.

F. Schena, G. Nanni, J. Morales, 2005, Transplantation proceedings.

A. Hartmann, N. Jamieson, W. Arns, 2009, Transplantation proceedings.

Early cyclosporine withdrawal from a sirolimus‐based regimen results in better renal allograft survival and renal function at 48 months after transplantation

G. Russ, A. Hartmann, J. Chapman, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

An equivalence study of the safety and efficacy of a fixed‐dose combination of perindopril with indapamide versus fixed‐dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension

C. Chastang, D. Guez, Y. Brault, 1995, Journal of hypertension.

Comparison of patient satisfaction with two different etanercept delivery systems

U. Müller-Ladner, R. Flipo, Y. Brault, 2012, Zeitschrift für Rheumatologie.

Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression*

J. Chapman, D. Hricik, Y. Brault, 2008, Transplant international : official journal of the European Society for Organ Transplantation.

Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study

P. Chanson, P. Caron, Y. Brault, 2020, Endocrine.

Pegvisomant treatment in acromegaly in clinical practice: final results of the French ACROSTUDY (312 patients).

P. Chanson, P. Caron, Y. Brault, 2021, Annales d'endocrinologie.

Clinical and electrophysiological study of the peripheral nervous system in the elderly

D. Guez, P. Bouche, Y. Brault, 1993, Journal of Neurology.

Treatment burden, adherence, and quality of life in children with daily GH treatment in France

O. Chassany, M. Tauber, Y. Brault, 2023, Endocrine connections.

Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus‐based therapy: a multivariate analysis of results at five years 1

R. Oberbauer, J. Morales, C. Legendre, 2007, Clinical transplantation.

Clinical and Ultrasound‐Based Composite Disease Activity Indices in Rheumatoid Arthritis: Results From a Multicenter, Randomized Study

M. Dougados, I. Logeart, W. Grassi, 2013, Arthritis care & research.

Identifying patients with rheumatoid arthritis with moderate disease activity at risk of significant radiographic progression despite methotrexate treatment

H. Nab, B. Fautrel, Y. Brault, 2015, RMD Open.

Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

Y. Brault, E. Salinas, P. Meoni, 2001, The Journal of clinical psychiatry.

Case-control study of the risk factors for age related macular degeneration

J. Sahel, G. Soubrane, Y. Brault, 1998, The British journal of ophthalmology.

SAT0473 Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the rheumatoid arthritis impact of disease (RAID)

M. Dougados, D. M. van der Heijde, I. Logeart, 2013 .

Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study.

G. Micali, J. Germain, L. Mallbris, 2015, Acta dermato-venereologica.

Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)

M. Dougados, D. M. van der Heijde, I. Logeart, 2012, Arthritis Research & Therapy.

Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized study.

M. Dougados, D. M. van der Heijde, I. Logeart, 2012, Arthritis and rheumatism.

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis

M. Dougados, Satrajit Roychoudhury, C. Bingham, 2022, RMD Open.

When to Adjust Therapy in Patients with Rheumatoid Arthritis After Initiation of Etanercept plus Methotrexate or Methotrexate Alone: Findings from a Randomized Study (COMET)

M. Dougados, D. M. van der Heijde, I. Logeart, 2014, Journal of Rheumatology.

Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes.

M. Dougados, I. Logeart, P. Hilliquin, 2012, Clinical and experimental rheumatology.

Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.

M. Dougados, L. Gossec, Y. Brault, 2017, Clinical and experimental rheumatology.

EARLY CYCLOSPORINE WITHDRAWAL FROM A SIROLIMUS-BASED REGIMEN RESULTS IN BETTER RENAL ALLOGRAFT SURVIVAL AND RENAL FUNCTION AT 48 MONTHS AFTER TRANSPLANTATION

G. Russ, A. Hartmann, J. Chapman, 2004, Transplant international : official journal of the European Society for Organ Transplantation.

Effect of a dopaminergic agonist, piribedil (Trivastal 50 mg LP), on visual and spatial integration in elderly subjects

C. Corbé, Y. Brault, F. Arnaud, 1992, Journal of Neurology.